VAISHALI PHARMA
Back to Balance Sheet
|
VAISHALI PHARMA Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹110 Cr | ₹80 Cr | ₹79 Cr | ₹81 Cr | ₹86 Cr |
What is the latest Total Liabilities ratio of VAISHALI PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹110 Cr |
| Mar2024 | ₹80 Cr |
| Mar2023 | ₹79 Cr |
| Mar2022 | ₹81 Cr |
| Mar2021 | ₹86 Cr |
How is Total Liabilities of VAISHALI PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹110 Cr | 37.45 | |
| Mar2024 | ₹80 Cr | 1.30 | |
| Mar2023 | ₹79 Cr | -3.32 | |
| Mar2022 | ₹81 Cr | -5.25 | |
| Mar2021 | ₹86 Cr | - | |
Compare Total Liabilities of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹91.0 Cr | -9.6% | -12.6% | -52.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -9.6% |
-12.6% |
-52.2% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses